{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:00:41Z","timestamp":1791216041919,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":6367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.exphem.2004.09.008","type":"journal-article","created":{"date-parts":[[2005,1,19]],"date-time":"2005-01-19T07:31:05Z","timestamp":1106119865000},"page":"53-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines"],"prefix":"10.1016","volume":"33","author":[{"given":"Sakura","family":"Sakajiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Phillip","family":"Koeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2004.09.008_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00062752-199907000-00002","article-title":"Epidemiology of leukemia and lymphoma","volume":"6","author":"Bhatia","year":"1999","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2004.09.008_bib2","series-title":"Harrison's Principles of Internal Medicine","first-page":"715","article-title":"Malignancies of lymphoid cells","author":"Armitage","year":"2001"},{"key":"10.1016\/j.exphem.2004.09.008_bib3","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2004.09.008_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07853899708998737","article-title":"Possibilities of gene therapies for cancer","volume":"29","author":"Lashford","year":"1997","journal-title":"Ann Med"},{"key":"10.1016\/j.exphem.2004.09.008_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00001622-200111000-00010","article-title":"Histone deacetylase inhibitors as new cancer drugs","volume":"13","author":"Marks","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.exphem.2004.09.008_bib6","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S1471-4914(02)02314-6","article-title":"Epigenomics and epigenetic therapy of cancer","volume":"8","author":"Brown","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.exphem.2004.09.008_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1568011033482440","article-title":"The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells","volume":"3","author":"Zhu","year":"2003","journal-title":"Curr Med Chem Anti-Canc Agents"},{"key":"10.1016\/j.exphem.2004.09.008_bib8","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood-2002-11-3514","article-title":"Molecular sequelae of histone deacetylase inhibition in human malignant B cells","volume":"101","author":"Mitsiades","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2004.09.008_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2004.09.008_bib10","first-page":"4791","article-title":"A gene expression profile that defines colon cell maturation in vitro","volume":"62","author":"Mariadason","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2004.09.008_bib11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1073\/pnas.2536759100","article-title":"Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications","volume":"101","author":"Mitsiades","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2004.09.008_bib12","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1093\/nar\/29.17.3603","article-title":"Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation","volume":"29","author":"Benjamin","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2004.09.008_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/5047","article-title":"Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer","volume":"21","author":"Cameron","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2004.09.008_bib14","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2003-03-0687","article-title":"Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2\u2032-deoxycytidine (decitabine) in hematopoietic malignancies","volume":"103","author":"Issa","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2004.09.008_bib15","first-page":"3578","article-title":"Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously","volume":"9","author":"Kelly","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2004.09.008_bib16","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/1078-0432.CCR-03-0100","article-title":"Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells","volume":"10","author":"Takai","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2004.09.008_bib17","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","article-title":"Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells","volume":"92","author":"Marks","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.exphem.2004.09.008_bib18","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.onc.1204252","article-title":"Regulation of the G2\/M transition by p53","volume":"20","author":"Taylor","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2004.09.008_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/viro.2002.1667","article-title":"Growth arrest of HPV-positive cells after histone deacetylase inhibition is independent of E6\/E7 oncogene expression","volume":"304","author":"Finzer","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.exphem.2004.09.008_bib20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0168-8278(02)00275-1","article-title":"Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor","volume":"37","author":"Rombouts","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.exphem.2004.09.008_bib21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1073\/pnas.0307708100","article-title":"Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1","volume":"101","author":"Gui","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2004.09.008_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/078538902321012405","article-title":"Induction of apoptosis in cancer: new therapeutic opportunities","volume":"34","author":"Ding","year":"2002","journal-title":"Ann Med"},{"key":"10.1016\/j.exphem.2004.09.008_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0014-5793(03)01186-4","article-title":"p15(INK4b) in HDAC inhibitor-induced growth arrest","volume":"554","author":"Hitomi","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.exphem.2004.09.008_bib24","first-page":"465","article-title":"Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals","volume":"9","author":"Vaziri","year":"1998","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.exphem.2004.09.008_bib25","doi-asserted-by":"crossref","first-page":"33981","DOI":"10.1074\/jbc.M005600200","article-title":"Inhibition of mitogenesis in Balb\/c-3T3 cells by Trichostatin A. Multiple alterations in the induction and activation of cyclin-cyclin-dependent kinase complexes","volume":"275","author":"Wharton","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2004.09.008_bib26","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1038\/sj.onc.1207050","article-title":"Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation","volume":"22","author":"Coombes","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2004.09.008_bib27","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1073\/pnas.191208598","article-title":"The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species","volume":"98","author":"Ruefli","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2004.09.008_bib28","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1038\/sj.onc.1207830","article-title":"Histone deacetylase inhibitors upregulate death receptor 5\/TRAIL-R2 and sensitize apoptosis induced by TRAIL\/APO2-L in human malignant tumor cells","volume":"23","author":"Nakata","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2004.09.008_bib29","first-page":"1273","article-title":"Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells","volume":"2","author":"Rosato","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.exphem.2004.09.008_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2141.2003.04761.x","article-title":"Molecular basis of mantle cell lymphoma","volume":"124","author":"Bertoni","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2004.09.008_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00277-003-0774-2","article-title":"Mantle cell lymphoma: established therapeutic options and future directions","volume":"83","author":"Lenz","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2004.09.008_bib32","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","article-title":"Mantle cell lymphoma\u2014an entity comes of age","volume":"87","author":"Weisenburger","year":"1996","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X04003224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X04003224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:19:23Z","timestamp":1759565963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X04003224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0301472X04003224"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2004.09.008","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2004.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}